DBC1 does not function as a negative regulator of SIRT1 in liver cancer

Bae,Hyun  Jin; Chang,Young  Gyoon; Noh,Ji  Heon; Kim,Jeong  Kyu; Eun,Jung  Woo; Jung,Kwang  Hwa; Kim,Min  Gyu; Shen,Qingyu; Ahn,Young  Min; Kwon,So  Hee; Park,Won  Sang; Lee,Jung  Young; Nam,Suk  Woo

doi:10.3892/ol.2012.875

November 2012 Volume 4 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

November 2012 Volume 4 Issue 5

Full Size Image

Article

DBC1 does not function as a negative regulator of SIRT1 in liver cancer

Authors:
- Hyun Jin Bae
- Young Gyoon Chang
- Ji Heon Noh
- Jeong Kyu Kim
- Jung Woo Eun
- Kwang Hwa Jung
- Min Gyu Kim
- Qingyu Shen
- Young Min Ahn
- So Hee Kwon
- Won Sang Park
- Jung Young Lee
- Suk Woo Nam
View Affiliations / Copyright

Affiliations: Laboratory of Oncogenomics, Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, Functional RNomics Research Center, The Catholic University of Korea, Seoul, Republic of Korea, Department of Kidney System, College of Oriental Medicine, Kyung Hee University, Seoul, Republic of Korea, College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Republic of Korea
Pages: 873-877
|
Published online on: August 23, 2012

https://doi.org/10.3892/ol.2012.875
Expand metrics +

Abstract

The putative tumor suppressor, DBC1 (deleted in breast cancer-1), was recently found to negatively regulate SIRT1 in vitro and in vivo, but the mechanism whereby DBC1 regulates SIRT1 in liver cancer remains to be elucidated. In this study, it was found that although the expression of DBC1 and SIRT1 was not aberrantly regulated in a large cohort of human hepatocellular carcinoma (HCC) patients, these proteins were highly overexpressed in a subset of HCC tissues compared with surrounding non-cancer tissues. In liver cancer, DBC1 and SIRT1 were found to be positively correlated. Inactivation of DBC1 or SIRT1 reduced SNU-182 (a liver cancer cell line) proliferation as determined by MTT viability assays. Notably, although DBC1 functions as a negative regulator of SIRT1 in A549 lung cancer cells since it suppresses the deacetylase activity of the p53 protein, it did not affect the p53 deacetylase activity of SIRT1 in SNU-182 cells. Taken together, we conclude that DBC1 is associated with SIRT1 in HCC, but that it does not inhibit SIRT1.

View Figures

View References

1.	A JemalF BrayMM CenterJ FerlayE WardD FormanGlobal cancer statisticsCA Cancer J Clin616990201110.3322/caac.20107
2.	S WhittakerR MaraisAX ZhuThe role of signaling pathways in the development and treatment of hepatocellular carcinomaOncogene2949895005201010.1038/onc.2010.23620639898
3.	Y ItoY SasakiM HorimotoActivation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellularcarcinomaHepatology27951958199810.1002/hep.5102704099537433
4.	CM WongST FanIO NgBeta-catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significanceCancer92136145200110.1002/1097-0142(20010701)92:1%3C136::AID-CNCR1301%3E3.0.CO;2-R11443619
5.	M HamaguchiJL MethC von KlitzingDBC2, a candidate for a tumor suppressor gene involved in breast cancerProc Natl Acad Sci USA991364713652200210.1073/pnas.212516099
6.	JE KimJ ChenZ LouDBC1 is a negative regulator of SIRT1Nature451583586200810.1038/nature0650018235501
7.	W ZhaoJP KruseY TangSY JungJ QinW GuNegative regulation of the deacetylase SIRT1 by DBC1Nature451587590200810.1038/nature0651518235502
8.	AM TrauernichtSJ KimNH KimTG BoyerModulation of estrogen receptor α protein level and survival function by DBC-1Mol Endocrinol21152615362007
9.	J FuJ JiangJ LiDeleted in breast cancer 1, a novel androgen receptor (AR) coactivator that promotes AR DNA-binding activityJ Biol Chem28468326840200910.1074/jbc.M80898820019126541
10.	S GarapatyCF XuP TrojerMA MahajanTA NeubertHH SamuelsIdentification and characterization of a novel nuclear protein complex involved in nuclear hormone receptor-mediated gene regulationJ Biol Chem28475427552200910.1074/jbc.M80587220019131338
11.	Z LiL ChenN KabraC WangJ FangJ ChenInhibition of SUV39H1 methyltransferase activity by DBC1J Biol Chem2841036110366200910.1074/jbc.M90095620019218236
12.	CC ChiniC EscandeV NinEN ChiniHDAC3 is negatively regulated by the nuclear protein DBC1J Biol Chem2854083040837201010.1074/jbc.M110.15327021030595
13.	DM HuffmanWE GrizzleMM BammanSIRT1 is significantly elevated in mouse and human prostate cancerCancer Res6766126618200710.1158/0008-5472.CAN-07-008517638871
14.	KY JangKS KimSH HwangExpression and prognostic significance of SIRT1 in ovarian epithelial tumoursPathology41366371200910.1080/0031302090288445119404850
15.	EJ ChaSJ NohKS KwonExpression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinomaClin Cancer Res1544534459200910.1158/1078-0432.CCR-08-332919509139
16.	W StunkelBK PehYC TanFunction of the SIRT1 protein deacetylase in cancerBiotechnol J213601368200710.1002/biot.20070008717806102
17.	J ChenB ZhangN WongSirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growthCancer Res7141384149201110.1158/0008-5472.CAN-10-427421527554
18.	C EscandeCC ChiniV NinDeleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in miceJ Clin Invest120545558201010.1172/JCI3931920071779
19.	JE KimZ LouJ ChenInteractions between DBC1 and SIRT 1 are deregulated in breast cancer cellsCell Cycle837843785200910.4161/cc.8.22.1005519855164
20.	E Ji YuSH KimK HeoCY OuMR StallcupJH KimReciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergyNucleic Acids Res3969326943201121596782
21.	A MenssenP HydbringK KapelleThe c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loopProc Natl Acad Sci USA201122190494
22.	R SundararajanG ChenC MukherjeeE WhiteCaspase-dependent processing activates the proapoptotic activity of deleted in breast cancer-1 during tumor necrosis factor-α-mediated death signalingOncogene2449084920200515824730
23.	H LeeKR KimSJ NohExpression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinomaHum Pathol42204213201010.1016/j.humpath.2010.05.02321056897
24.	EJ KimJH KhoMR KangSJ UmActive regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activityMol Cell28277290200710.1016/j.molcel.2007.08.03017964266
25.	H KangJW JungMK KimJH ChungCK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damagePLoS One4e6611200910.1371/journal.pone.000661119680552
26.	Y YangW FuJ ChenSIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stressNat Cell Biol912531262200710.1038/ncb164517934453
27.	L McKendrickD MilneD MeekProtein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stableMol Cell Biochem191187199199910.1023/A:1006854109926
28.	R BennettY PanJ ChristianT HuiWS May JrThe RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation, leading to G₁ arrestCell Cycle11407417201210.4161/cc.11.2.1899922214662
29.	JF ReidM GariboldiV SokolovaIntegrative approach for prioritizing cancer genes in sporadic colon cancerGenes Chromosomes Cancer48953962200910.1002/gcc.2069719672874

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

DBC1 does not function as a negative regulator of SIRT1 in liver cancer

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles